Search

Search Results

• Awareness assessment for viral hepatitis among patients in different departments of medical institutions and students.

  A. M. Loboda, N. G. Malysh, O. K. Melekhovets, O. M. Chemych, V. I. Mogylenko, D. V. Osypko

  185-196

  2021-05-29
• Personified treatment and prevention of sexual developmental disorders in pubertal age girls with diffusive liver diseases

  E. F. Chaykivska

  330-353

  2020-01-31
• Clinical and epidemiological features of chronic hepatitis C in the north-western region of Ukraine

  T. I. Bevz

  281-290

  2020-02-28
• The value of polymorphism + 3725G / C TLR4 gene as a marker of liver fibrosis progression in patients with chronic hepatitis C

  T. I. Bevz, D. F. Kyrychenko, G. A. Martynyuk

  328-336

  2019-10-30
• Opportunities for the use of natural and preformed physical factors in the complex treatment of patients with chronic viral hepatitis C with associated non-alcoholic fatty liver disease

  Аnna Izha

  254-263

  2019-12-28
• Features of clinical course of chronic hepatitis in children with oenological diseases

  I. I. Nezgoda, L. V. Moroz, S. Singh, O. O. Singh

  880-896

  2017-04-25
• Тhe role of the internal use of mineral water in the complex treatment of patients with chronic viral hepatitis C with concomitant non-alcoholic fatty liver disease

  Anna Izha

  226-235

  2020-01-31
• Рrospects for the use of “dry” carbon dioxide baths in patients with chronic viral hepatitis c with concomitant non-alcoholic fatty liver disease (literature review and own research)

  Anna Izha

  341-349

  2020-06-30
• Hormonal profile of pubertal age girls with chronic viral hepatitis

  E. F. Chaykivska

  342-350

  2020-04-30
• Laboratory-biochemical features of the course of chronic hepatitis C with polymorphism rs11536889 + 3725G/C of TLR-4 gene

  T. I. Bevz, G. A. Martynyuk, L. A. Livshits, Y. M. Demchyshyn

  254-261

  2020-04-30
• Dependence of changes in hematological and integrative parameters in patients with chronic viral hepatitis C on the received antiviral therapy

  A. H. Lishnevska, M. D. Chemych

  177-195

  2020-02-28
• The role of interleukin-17 gene polymorphism (RS612242 C11139G) in the formation of the cryoglobulinemic syndrome in patients with chronic hepatitis C

  K. V. Kalashnyk, Yu. Yu. Riabokon

  248-258

  2019-11-29
• Comparison of the diagnostic efficiency of various noninvasive methods for diagnosing liver fibrosis in patients with chronic viral hepatitis C

  L. V. Moroz, I. Yu. Bondaruk, A. A. Popovich, S. N. Kulias

  546-555

  2019-06-28
• Clinical and psychopathological features of the course and outcome of the first psychotic episode.

  Yuri Bazhora, Valentyn Gudz, Valentina Mozgova, Kateryna Usychenko, Nikol Shvets

  279-286

  2023-11-30
• Ultrasonographic characteristics of morphometric and hemodynamic parameters of the liver and spleen in pediatric patients with chronic viral hepatitis B and C

  Y. Demchyshyn, I. Nezgoda, S. Poprotska, A. Asaulenko

  201-206

  2021-11-30
• Morphological changes in kidney glomeruli of rats with chronic toxic hepatitis and its correction with lisinopril, L-arginine-L-glutamate and their combination

  N. A. Rykalo, Yu. M. Berehovenko, O. V. Androshchuk

  632-639

  2019-05-27
• Фармакотерапия хронического гепатита С, ассоциированного с аутоиммунным тиреоидитом = Pharmacotherapy of chronic hepatitis C, associated with autoimmune thireoiditis

  T. V. Tregub

  705-710

  2016-11-30
• Renal dysfunction in patients with chronic toxic hepatitis and ways of its correction

  O. Kvasnytska, A. Gozhenko

  183-189

  2023-05-31
• Дослідження фаз клітинного циклу та плоїдності ядерної ДНК клітин печінки статевонезрілих щурів при хронічному токсичному гепатиті та корекції лізиноприлом = Research of cell cycle phases and nuclear DNA ploidy in immature liver cells of rats with chronic toxic hepatitis and lisinopril correction

  N. A. Rikalo, Y. M. Beregovenko

  219-228

  2016-01-30
• Relationshipof clinical course, biochemical and immunological changes in patients with chronic hepatitis B+C

  K. Usychenko

  152-160

  2023-05-31
• Механізми репаративної регенерації тканини печінки у статевонезрілих щурів при хронічному токсичному гепатиті = The mechanisms of reparative regeneration of liver tissue in immature rats at chronic toxic hepatitis

  N. A. Rikalo

  587-598

  2015-09-30
• Influence of complex treatment with quercetin inclusion on cytokine profile indicators in chronic nonviral hepatitis patients

  V. P. Prysyazhnyuk

  177-185

  2017-10-30
• Disorders peculiarities of the bile-formed and bile-excreting liver functions in the early period of traumatic disease on the background of chronic hepatitis

  R. Blyzniuk, T. Dzetsiukh

  61-68

  2015-10-13
• Comparison of diagnostic informative value of the methods for the determination of direct (hyaluronic acid) and indirect (alanine aminotransferase, aspartate aminotransferase, de Rithis coefficient) of liver fibrosis markers in patients with chronic viral hepatitis C

  L. V. Moroz, I. Yu. Bondaruk

  676-688

  2019-05-27
• Relationship of cytokine gene polymorphism and the development of liver fibrosis in patients with chronic hepatitis B&C

  K. Usychenko, Y. Berdnyk

  339-348

  2023-02-24
• DAA - directly acting antivirals - as a new, more efficient solution of the chronic hepatitis C treatment and theirs various application.

  Kamila Abram, Patryk Banaś, Justyna Adamus, Jakub Rafał Pierzchała, Katarzyna Bednarz, Natalia Sobańska, Aleksandra Paulina Banasiak, Rafał Teichman, Jakub Kasprowicz, Michał Hyjek

  200-206

  2023-02-02
• The dynamics of cytolytic syndrome parameters in the period of late manifestations of cranioskeletal trauma in case of concomitant chronic hepatitits and the effectiveness of armadine correction

  O. Prokhorenko

  392-401

  2021-11-30
• New diagnostic markers for the degree of liver fibrosis in children with chronic viral hepatitis

  I. I. Nezgoda, L. V. Moroz, S. Singh, O. O. Singh

  1040-1055

  2017-06-30